Hak‐Myung Lee

634 total citations
20 papers, 474 citations indexed

About

Hak‐Myung Lee is a scholar working on Physiology, Surgery and Nutrition and Dietetics. According to data from OpenAlex, Hak‐Myung Lee has authored 20 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 7 papers in Surgery and 7 papers in Nutrition and Dietetics. Recurrent topics in Hak‐Myung Lee's work include Clinical Nutrition and Gastroenterology (6 papers), Parathyroid Disorders and Treatments (5 papers) and Thyroid and Parathyroid Surgery (5 papers). Hak‐Myung Lee is often cited by papers focused on Clinical Nutrition and Gastroenterology (6 papers), Parathyroid Disorders and Treatments (5 papers) and Thyroid and Parathyroid Surgery (5 papers). Hak‐Myung Lee collaborates with scholars based in United States, United Kingdom and Denmark. Hak‐Myung Lee's co-authors include Douglas L. Seidner, Palle Bekker Jeppesen, Simon Gabe, Kishore Iyer, Joseph I. Boullata, Thomas R. Ziegler, Ken Fujioka, Michael Mannstadt, B.L. Clarke and Tamara Vokes and has published in prestigious journals such as Gastroenterology, The Journal of Clinical Endocrinology & Metabolism and Journal of Hepatology.

In The Last Decade

Hak‐Myung Lee

20 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hak‐Myung Lee United States 11 241 167 146 104 83 20 474
Rachel Stovold United Kingdom 9 107 0.4× 214 1.3× 59 0.4× 181 1.7× 119 1.4× 13 470
Andreas Brønden Denmark 17 34 0.1× 246 1.5× 100 0.7× 18 0.2× 78 0.9× 36 619
A. Adler Germany 4 47 0.2× 314 1.9× 54 0.4× 116 1.1× 14 0.2× 4 471
Huan Zheng China 13 35 0.1× 54 0.3× 35 0.2× 22 0.2× 58 0.7× 31 354
G. Hedenborg Sweden 11 29 0.1× 104 0.6× 30 0.2× 21 0.2× 46 0.6× 32 360
Rafael Kemp Brazil 11 26 0.1× 257 1.5× 46 0.3× 128 1.2× 44 0.5× 65 479
Fumihiko Kinekawa Japan 10 86 0.4× 125 0.7× 30 0.2× 44 0.4× 103 1.2× 22 360
Markus Goldschmiedt United States 11 29 0.1× 266 1.6× 32 0.2× 98 0.9× 153 1.8× 20 417
Brent Freeman United States 8 25 0.1× 255 1.5× 43 0.3× 92 0.9× 10 0.1× 12 505
A. Justin Rucker United States 10 79 0.3× 54 0.3× 28 0.2× 85 0.8× 3 0.0× 15 312

Countries citing papers authored by Hak‐Myung Lee

Since Specialization
Citations

This map shows the geographic impact of Hak‐Myung Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hak‐Myung Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hak‐Myung Lee more than expected).

Fields of papers citing papers by Hak‐Myung Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hak‐Myung Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hak‐Myung Lee. The network helps show where Hak‐Myung Lee may publish in the future.

Co-authorship network of co-authors of Hak‐Myung Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Hak‐Myung Lee. A scholar is included among the top collaborators of Hak‐Myung Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hak‐Myung Lee. Hak‐Myung Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Argente, Jesús, Charles F. Verge, Ilene Fennoy, et al.. (2024). Setmelanotide in patients aged 2–5 years with rare MC4R pathway-associated obesity (VENTURE): a 1 year, open-label, multicenter, phase 3 trial. The Lancet Diabetes & Endocrinology. 13(1). 29–37. 12 indexed citations
2.
3.
Newsome, Philip N., Melissa Palmer, Bradley Freilich, et al.. (2020). Volixibat in adults with non-alcoholic steatohepatitis: 24-week interim analysis from a randomized, phase II study. Journal of Hepatology. 73(2). 231–240. 65 indexed citations
4.
Pape, Ulrich‐Frank, Kishore Iyer, Palle Bekker Jeppesen, et al.. (2020). Teduglutide for the treatment of adults with intestinal failure associated with short bowel syndrome: pooled safety data from four clinical trials. Therapeutic Advances in Gastroenterology. 13. 3974094630–3974094630. 37 indexed citations
5.
Mannstadt, Michael, B.L. Clarke, John P. Bilezikian, et al.. (2019). Safety and Efficacy of 5 Years of Treatment With Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism. The Journal of Clinical Endocrinology & Metabolism. 104(11). 5136–5147. 47 indexed citations
6.
Armstrong, David, Alastair Forbes, Palle Bekker Jeppesen, et al.. (2019). Colon polyps in patients with short bowel syndrome before and after teduglutide: Post hoc analysis of the STEPS study series. Clinical Nutrition. 39(6). 1774–1777. 23 indexed citations
7.
Jeppesen, Palle Bekker, Simon Gabe, Douglas L. Seidner, Hak‐Myung Lee, & Olivier Clément. (2019). Citrulline correlations in short bowel syndrome–intestinal failure by patient stratification: Analysis of 24 weeks of teduglutide treatment from a randomized controlled study. Clinical Nutrition. 39(8). 2479–2486. 16 indexed citations
8.
Bilezikian, John P., Henry G. Bone, B.L. Clarke, et al.. (2019). OR30-1 Safety and Efficacy of Recombinant Human Parathyroid Hormone 1-84 for the Treatment of Adults with Chronic Hypoparathyroidism: Six-Year Results of the RACE Study. Journal of the Endocrine Society. 3(Supplement_1). 1 indexed citations
9.
Seidner, Douglas L., et al.. (2019). Enteral Autonomy and Days Off Parenteral Support With Teduglutide Treatment for Short Bowel Syndrome in the STEPS Trials. Journal of Parenteral and Enteral Nutrition. 44(4). 697–702. 31 indexed citations
10.
Seidner, Douglas L., Ken Fujioka, Joseph I. Boullata, et al.. (2018). Reduction of Parenteral Nutrition and Hydration Support and Safety With Long‐Term Teduglutide Treatment in Patients With Short Bowel Syndrome−Associated Intestinal Failure: STEPS‐3 Study. Nutrition in Clinical Practice. 33(4). 520–527. 64 indexed citations
11.
12.
Bilezikian, John P., B.L. Clarke, Michael Mannstadt, et al.. (2017). Safety and Efficacy of Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism Randomly Assigned to Receive Fixed 25-μg or 50-μg Daily Doses. Clinical Therapeutics. 39(10). 2096–2102. 17 indexed citations
13.
Jeppesen, Palle Bekker, et al.. (2017). Factors Associated With Response to Teduglutide in Patients With Short-Bowel Syndrome and Intestinal Failure. Gastroenterology. 154(4). 874–885. 99 indexed citations
14.
15.
Elstein, Deborah, T. Burrow, Joel Charrow, et al.. (2016). Home infusion of intravenous velaglucerase alfa: Experience from pooled clinical studies in 104 patients with type 1 Gaucher disease. Molecular Genetics and Metabolism. 120(1-2). 111–115. 9 indexed citations
16.
O’Keefe, Stephen J., Ulrich‐Frank Pape, Hak‐Myung Lee, Andrew A. Grimm, & Palle Bekker Jeppesen. (2016). Subanalysis of Teduglutide Efficacy and Safety Data from Patients with Crohnʼs Disease and Ulcerative Colitis in the STEPS Study. The American Journal of Gastroenterology. 111. S265–S265. 2 indexed citations
17.
Smith, Laurie D., William J. Rhead, Joel Charrow, et al.. (2015). Long-term velaglucerase alfa treatment in children with Gaucher disease type 1 naïve to enzyme replacement therapy or previously treated with imiglucerase. Molecular Genetics and Metabolism. 117(2). 164–171. 26 indexed citations
18.
Ida, Hiroyuki, Akemi Tanaka, Kei Murayama, et al.. (2015). A multicenter, open-label extension study of velaglucerase alfa in Japanese patients with Gaucher disease: Results after a cumulative treatment period of 24 months. Blood Cells Molecules and Diseases. 59. 140–147. 8 indexed citations
19.
Viana, Marios A. G. & Hak‐Myung Lee. (2006). Correlation analysis of ordered symmetrically dependent observations and their concomitants of order statistics. Canadian Journal of Statistics. 34(2). 327–340. 7 indexed citations
20.
Lee, Hak‐Myung & Marlos A. G. Viana. (1999). The joint covariance structure of ordered symmetrically dependent observations and their concomitants of order statistics. Statistics & Probability Letters. 43(4). 411–414. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rachel Stovold Breakdown of academic impact, for papers by Andreas Brønden Breakdown of academic impact, for papers by A. Adler Breakdown of academic impact, for papers by Huan Zheng Breakdown of academic impact, for papers by G. Hedenborg Breakdown of academic impact, for papers by Rafael Kemp Breakdown of academic impact, for papers by Fumihiko Kinekawa Breakdown of academic impact, for papers by Markus Goldschmiedt Breakdown of academic impact, for papers by Brent Freeman Breakdown of academic impact, for papers by A. Justin Rucker
Rankless by CCL
2026